PLANO, Texas, Sept. 30, 2026 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading global medical device contract development and manufacturing organization (CDMO), today announced that it has received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with the previously announced acquisition of Integer by an affiliate of investment funds managed by KKR (the “Merger”).
NEXT10 Outlines Strategy to Build BFCH Into a High-Growth Health-and-Wellness Platform
Strategic transaction aligns NXTN and BFCH around a separately traded wellness platform combining operating assets, experienced leadership and multiple ave
Harrison Street Asset Management to Acquire Majority Stake in Vicinity Energy, Largest U.S. Provider of District Energy Solutions
Harrison Street signs agreement to acquire Vicinity Energy – the largest provider of district energy solutions in the United States.
Harrison Street Asset Management to Acquire Majority Stake in Vicinity Energy, Largest U.S. Provider of District Energy Solutions
Harrison Street signs agreement to acquire Vicinity Energy – the largest provider of district energy solutions in the United States.
Form 8.3 – Vesuvius Plc
FORM 8.3
Form 8.3 – Vesuvius Plc
FORM 8.3
ENT & Allergy Associates Expands Pennsylvania Footprint with Melissa Schwartz, DO, and New Elkins Park Clinical Site
ENT & Allergy Associates of Pennsylvania today announced the addition of otolaryngologist Melissa Schwartz, DO, and her established clinical practice at 375 Township Line Road in Elkins Park, PA, effective January 1, 2027.
ENT & Allergy Associates of Pennsylvania today announced the addition of otolaryngologist Melissa Schwartz, DO, and her established clinical practice at 375 Township Line Road in Elkins Park, PA, effective January 1, 2027.
Italfarmaco Presents New Givinostat (Duvyzat®) Clinical Data Supporting Preservation of Upper Limb Function in Duchenne Muscular Dystrophy Patients at the 2026 World Muscle Society Congress
MILAN, Italy, September 30, 2026 – Italfarmaco S.p.A. today announced new long-term data from the ongoing Phase 3 EPIDYS open-label extension (OLE) study showing that treatment with givinostat (Duvyzat®) may help preserve upper limb function in boys with Duchenne muscular dystrophy (DMD). The findings, presented at the 31st Annual International Congress of the World Muscle Society (WMS), provide further evidence supporting the long-term clinical benefits of givinostat across multiple measures of disease progression.
John Brandsema, MD, Paediatric Neurologist in the Division of Neurology at Children’s Hospital of Philadelphia, presented the poster “Trajectory of Performance of Upper Limb in Patients With Duchenne Muscular Dystrophy Treated With Givinostat Relative to a Modeled Natural History Cohort from a Single Centre,” which compared upper limb function in givinostat-treated patients with counterfactual trajectories estimated from an external natural history-based model representing predicted disease progression in the absence of treatment, using the Performance of Upper Limb 2.0 (PUL 2.0) assessment. Upper limb function is an increasingly important measure of disease progression as DMD advances and loss of ambulation occurs.
“Preserving upper limb function is critically important for people living with Duchenne because it directly affects independence and the ability to perform everyday activities,” said Scott Baver, PhD, VP, Head of Global Medical Affairs, Rare Diseases. “These new findings extend our understanding of givinostat beyond ambulatory outcomes and provide exploratory evidence suggesting a potential effect on the preservation of upper limb function, an important aspect of disease progression for people living with DMD.”
“Upper limb function becomes increasingly important as Duchenne progresses because it has a direct impact on independence and participation in daily life,” said John Brandsema, MD, Paediatric Neurologist at Children’s Hospital of Philadelphia and presenter of the analysis. “Preserving upper limb function is an outcome that matters greatly to patients and families.”
Key findings:
These exploratory analyses compared observed outcomes in patients receiving givinostat with predicted outcomes generated from an external natural history-based model and should be interpreted within the context of this study design.
Octane Rent Launches U.S. Operations with Miami Expansion
Miami, Florida, USA, Sept. 30, 2026 (GLOBE NEWSWIRE) — 
Dubai-based luxury car rental company brings its 400+ vehicle, 31-brand fleet to Florida, extending a model built over 27 years of combined operating history.
Silicon Anode Materials Market Size to Hit USD 44.16 Billion by 2035 at 42.62% CAGR | SNS Insider
SNS Insider Estimates, the Silicon Anode Materials Market is projected to reach USD 44.16 billion by 2035, growing at a 42.62% CAGR, while the U.S. market is projected to reach USD 8.00 billion, advancing at 40.60% CAGR, as battery makers pursue higher energy density.
SNS Insider Estimates, the Silicon Anode Materials Market is projected to reach USD 44.16 billion by 2035, growing at a 42.62% CAGR, while the U.S. market is projected to reach USD 8.00 billion, advancing at 40.60% CAGR, as battery makers pursue higher energy density.
Onzekerheid veroorzaakt de werkelijke cloudkosten: voorspelbaarheid in de cloud inbouwen
Amsterdam, Nederland. 30 september 2026 – Nu infrastructuurstrategieën door disruptieve ontwikkelingen veranderen, bespreekt Sean Tilley, Senior Director of Sales EMEA bij 11:11 Systems, een leverancier van beheerde infrastructuuroplossingen, hoe overhaaste beslissingen over de cloud kapitaalzekerheid inruilen voor operationele onduidelijkheid.